Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Manitex Capital Inc. (V:MNX)

Business Focus: Pharmaceuticals (NEC)

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for MNX within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Feb 28, 2024 17:43 ET
Manitex Capital Reports Annual Financial Results
KIRKLAND, QC, Feb. 28, 2024 /CNW/ - Manitex Capital Inc. ("Manitex") reported today its financial results for the year ended October 31, 2023.
Read full article
Oct 12, 2023 19:33 ET
Manitex Capital Announces Change of Auditor
KIRKLAND, QC, Oct. 12, 2023 /CNW/ - Manitex Capital Inc. (TSXV: MNX) ("Manitex" or the "Company") today announced that it has changed its auditor from MNP LLP (the "Former Auditor") to Audacie inc. (formerly, Guimond Lavallée Inc.) (the "Successor Auditor").
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
--
3.85
3.46
Price to Book - most recent quarter
0.28
2.75
2.02
Price to Cash Flow per share - TTM
1.67
7.41
9.70
Price to Free Cash Flow per share - TTM
--
19.71
12.33
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Nov 30, 2023710
Nov 15, 202371-10,000
Oct 31, 202310,0710
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Manitex Capital Inc. is a Canada-based Diversified investment company. The Company is specialized in investing in emerging as well as established companies in diversified sectors, including life sciences and sustainable products/technologies. The Company also holds an extensive portfolio in marketable securities in companies in the same fields.

See business summary

 

Twitter

Search (past week) for $MNX.CA MNX.V

  • No tweets found